Manipal > Institutions > Regenerative Medicine > MIRM Bangalore > Research


Journals and Publications 


 All International (Indexed)

  1. Chiruvella KK, Kari V, Choudhary B, Nambiar M, Ghanta RG, Raghavan SC. Methyl angolensate, a natural tetranortriterpenoid induces intrinsic apoptotic pathway in leukemic cells. FEBS Lett. 2008 Dec 10;582(29):4066-76.
  2. Nambiar M, Choudhary B, Rao CR, Raghavan SC. Amplification of chromosomal translocation junctions from paraffin-embedded tissues of follicular lymphoma patients. Biomed Mater. 2008 Sep;3(3):034103.
  3. Deb KD, Jayaprakash AD, Sharma V, Totey S. Embryonic stem cells: from markers to market.. Rejuvenation Res. 2008 Feb;11(1):19-37.
  4. Kavitha CV, Nambiar M, Ananda Kumar CS, Choudhary B, Muniyappa K, Rangappa KS, Raghavan SC. Novel derivatives of spirohydantoin induce growth inhibition followed by apoptosis in leukemia cells. Biochem Pharmacol. 2009 Feb 1;77(3):348-63.
  5. Sivasubramaniyan K, Atluri RR, Sarda K, Arvind M, Balaji V, Deb KD. Endotoxin-induced silencing of mesoderm induction and functional differentiation: role of HMGB1 in pluripotency and infection. Regen Med. 2008 Jan;3(1):23-31.
  6. Deb KD, Sarda K. Human embryonic stem cells: preclinical perspectives. J Transl Med. 2008 Jan 29;6:7.
  7. Saxena S, Hanwate M, Deb K, Sharma V, Totey S FGF2 secreting human fibroblast feeder cells: a novel culture system for human embryonic stem cells.Mol Reprod Dev. 2008 Oct;75(10):1523-32.
  8. Pal R, Hanwate M, Jan M, Totey S. Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med. 2009 Mar;3(3):163-74.
  9. Pal R, Hanwate M, Totey SM. Effect of holding time, temperature and different parenteral solutions on viability and functionality of adult bone marrow-derived mesenchymal stem cells before transplantation. J Tissue Eng Regen Med. 2008 Oct;2(7):436-44.
  10. Saxena S, Hanwate M, Deb K, Sharma V, Totey S. FGF2 secreting human fibroblast feeder cells: a novel culture system for human embryonic stem cells. Mol Reprod Dev. 2008 Oct;75(10):1523-32.
  11. Pal R, Hanwate M, Jan M, Totey S. Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow-derived mesenchymal stem cells. J Tissue Eng Regen Med. 2009 Mar;3(3):163-74.
  12. Pal R. Embryonic stem (ES) cell-derived cardiomyocytes: a good candidate for cell therapy applications. Cell Biol Int. 2009 Mar;33(3):325-36.
  13. Deb K. A sweet potion to put embryonic stem cells to sleep. ScientificWorldJournal. 2009 Mar 31;9:236-49.
  14. Deb KD, Jayaprakash AD, Sharma V, Totey S. Embryonic stem cells: from markers to market. Rejuvenation Res. 2008 Feb;11(1):19-37. Review.
  15. Nekanti U, Rao VB, Bahirvani AG, Jan M, Totey S, Ta M. Long-term Expansion and Pluripotent Marker Array Analysis of Wharton's Jelly-Derived Mesenchymal Stem Cells. Stem Cells Dev. 2010 Jan;19(1):117-30.
  16. Pal R, Totey S, Mamidi MK, Bhat VS, Totey S. Propensity of human embryonic stem cell lines during early stage of lineage specification controls their terminal differentiation into mature cell types. Exp Biol Med (Maywood). 2009 Oct;234(10):1230-43.
  17. Gupta PK, R. Saxena, E. Adamtziki, U. Budde, F. Oyen, T.Obser, R. Schneppenheim. Genetic defects in von Willebrand disease type 3 in Indian and Greek patients. Blood Cells Mol Dis. 2008 Sep-Oct;41(2):219-22
  18. Gambhir R, Gupta PK, Choudhary RK. Prothrombotic work up in vascular thrombosis – are we guilty of under assessment? British Journal of Surgery. 2008; 95(S3): 1–84 (Abst 0907)
  19. Gambhir R, Malhotra M, Gupta PK. Therapeutic angiogenesis in non-reconstructable critical limb Ischemia: a ray of hope. British Journal of Surgery. 2008; 95(S3): 1–84 (Abst 0899)
  20. Gupta PK, Ahuja A, Kumar H, Sarkar r, Mehta A. Role of Protein Z and its association with factor V Leiden mutation in thrombophilia amongst Indians. Int Jnl Lab Hem. 2008; 30: (Sl) 58 – 147 (Abst 410)
  21. S. Jyothi prasanna, Divya Gopalakrishnan, Shilpa Rani Shankar, B.V. Anoop. Pro-inflammatory Cytokines, IFN  ¥ and TNF α Influence Immune properties of Human Bone Marrow and Wharton jelly Mesenchymal Stem Cells Differentially" Accepted for Publication in PLoS One 2009
  22. Venkataramana NK, Kumar SK, Balaraju S, Radhakrishnan RC, Bansal A, Dixit A, Rao DK, Das M, Jan M, Gupta PK, Totey SM. An Open labeled study of unilateral autologous bone marrow derived mesenchymal stem cells transplantation in Parkinson’s disease. Transl Res. 2010 Feb;155(2):62-70.
  23. Totey MS, Totey S, Pal R, Pal R. Adult Stem Cells: A Clinical Update. J Stem Cells. 2009; 4(2): 105-122.
  24. Sivasubramaniyan K, Pal R, Totey S, Bhat VS, Totey S. Rho Kinase Inhibitor Y27632 Alters the Balance Between Pluripotency and Early Differentiation Events in Human Embryonic Stem Cells. Curr Stem Cell Res Ther. 2009 Dec 2.
  25. Sivasubramaiyan K, Totey S, Bhat V, Totey SM, Deb K. Y-27632 enhances differentiation of blastocyst like cystic human embryoid bodies to endocrinologically active trophoblast cells on a biomimetic platform. J Biomed Sci. 2009 Sep 22; 16: 88.
  26. Gupta PK, Venkataramana NK, Rao S, Murogod U, Totey S. Use of Human Mesenchymal Stem Cells in Neurological and other disorders. Regenerative Medicine. Nov 2009. Vol 4, No. 6 (Suppl 2) S – 93